CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 259 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3,198,713 | +475.8% | 192,926 | +546.0% | 0.02% | +466.7% |
| Q4 2022 | $555,508 | -58.0% | 29,866 | -71.0% | 0.00% | -66.7% |
| Q3 2022 | $1,322,000 | +551.2% | 103,008 | +321.6% | 0.01% | +800.0% |
| Q1 2022 | $203,000 | -17.5% | 24,431 | -32.6% | 0.00% | 0.0% |
| Q4 2021 | $246,000 | +30.2% | 36,271 | -26.1% | 0.00% | -50.0% |
| Q1 2020 | $189,000 | +243.6% | 49,050 | +242.2% | 0.00% | – |
| Q2 2019 | $55,000 | -21.4% | 14,332 | -60.9% | 0.00% | – |
| Q4 2018 | $70,000 | -40.2% | 36,700 | +18.3% | 0.00% | -100.0% |
| Q3 2018 | $117,000 | +50.0% | 31,012 | +24.0% | 0.00% | – |
| Q2 2018 | $78,000 | – | 25,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $2,458 | 7.14% |
| GABLES CAPITAL MANAGEMENT INC. | 409,080 | $6,782,546 | 4.74% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,355,099 | $171,687,541 | 3.83% |
| JW Asset Management, LLC | 563,392 | $9,341,039 | 3.58% |
| Quantedge Capital Pte Ltd | 324,700 | $5,383,526 | 2.10% |
| Paradiem, LLC | 236,628 | $3,923,292 | 1.22% |
| SummerHaven Investment Management, LLC | 100,592 | $1,667,815 | 0.97% |
| Capital Impact Advisors, LLC | 46,096 | $764,272 | 0.94% |
| Yorktown Management & Research Co Inc | 50,000 | $829,000 | 0.89% |
| Seaport Global Advisors, LLC | 15,598 | $258,615 | 0.82% |